Stockscreener 앱 받기
19.81
0.76%
0.15
시간 외 거래:
19.18
-0.63
-3.18%
전일 마감가:
$19.66
열려 있는:
$19.6
하루 거래량:
764.54K
Relative Volume:
0.54
시가총액:
$1.37B
수익:
$796.00M
순이익/손실:
$-136.49M
주가수익비율:
-9.4785
EPS:
-2.09
순현금흐름:
$-64.24M
1주 성능:
-4.07%
1개월 성능:
-8.92%
6개월 성능:
-53.33%
1년 성능:
-43.88%
1일 변동 폭
$19.18
$19.84
1주일 범위
$19.11
$21.15
52주 변동 폭
$17.64
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
19.81 | 1.37B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
131.35 | 227.80B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.80 | 149.09B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
367.54 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.98 | 114.12B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.19 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Tandem Diabetes Care Insiders Sell US$1.5m Of Stock, Possibly Signalling Caution - Simply Wall St
Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.6% on Mar 26 - GuruFocus.com
3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology - MSN
Stifel maintains Tandem Diabetes Care stock Buy rating, $60 target By Investing.com - Investing.com UK
(TNDM) Long Term Investment Analysis - Stock Traders Daily
Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock? - MSN
Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights - Investing.com
Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Tandem announces publication of results from trial of Control-IQ+ AID technology - Yahoo Finance
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data - Yahoo Finance
Tandem’s Control-IQ+ looks like a smart move for insulin-using T2D - BioWorld Online
Tandem reports A1C reduction in type 2 diabetes study By Investing.com - Investing.com South Africa
Tandem Diabetes Launches Next-Gen Automated Insulin Delivery Algorithm in U.S. - MPO-mag
Tandem reports A1C reduction in type 2 diabetes study - Investing.com India
Breakthrough: Tandem's Control-IQ+ Slashes A1C Levels by 0.9% in Landmark NEJM Study - StockTitan
Automated Insulin Delivery System Helps in Type 2 Diabetes - Medscape
Tubeless Insulin Pump Market Is Booming Worldwide | Medtronic - openPR
Tandem Diabetes Care launches Control-IQ+ automated insulin delivery technology in the US - Marketscreener.com
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States - Enid News & Eagle
3 Healthcare Stocks Walking a Fine Line - Yahoo Finance
Revolutionary Diabetes Treatment: Tandem's New Control-IQ+ Expands Access to Automated Insulin Delivery - StockTitan
Artificial Pancreas (Closed-Loop Insulin Delivery) Market - openPR
Tandem Diabetes Care (NASDAQ:TNDM) Trading Up 6.1% Following Insider Buying Activity - Defense World
Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings - MSN
Tandem Diabetes at Leerink Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
Victory Capital Management Inc. Decreases Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Bank of New York Mellon Corp Purchases 4,130 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care’s SWOT analysis: stock outlook amid market challenges - Investing.com
Keybank National Association OH Has $245,000 Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock By Investing.com - Investing.com South Africa
Tandem Diabetes EVP Kyrillos purchases $190,966 in company stock - Investing.com
Reasons to Hold TNDM Stock in Your Portfolio for Now - Nasdaq
Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity - TipRanks
Smartleaf Asset Management LLC Acquires 1,101 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by US Bancorp DE - Defense World
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Oppenheimer & Co. Inc. - Defense World
TANDEM DIABETES CARE, INC. (NASDAQ:TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. - ACCESS Newswire
Tandem Diabetes Care stock hits 52-week low at $18.27 By Investing.com - Investing.com Australia
Tandem Diabetes Care stock hits 52-week low at $18.27 - Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Position Increased by Private Advisor Group LLC - Defense World
Morgan Stanley Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Equal Weight - Defense World
Tandem Diabetes Care (NASDAQ:TNDM) Rating Lowered to Neutral at Citigroup - Defense World
Morgan Stanley Downgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes Care downgraded to Equal-weight on guidance concerns - MSN
Tandem Diabetes Care Shares Edge Lower After Downgrade From Morgan Stanley -March 05, 2025 at 02:34 pm EST - Marketscreener.com
Morgan Stanley Downgrades Tandem Diabetes Care (LSE:0M0F) - Nasdaq
This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga India
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
3.69%
자본화:
|
볼륨(24시간):